Form S-4/A - Registration of securities, business combinations: [Amend]
SEC Accession No. 0001104659-25-024021
Filing Date
2025-03-14
Accepted
2025-03-14 17:16:00
Documents
35

Document Format Files

Seq Description Document Type Size
1 S-4/A tm253007-7_s4a.htm S-4/A 8584738
2 EXHIBIT 5.1 tm253007d9_ex5-1.htm EX-5.1 14605
3 EXHIBIT 8.1 tm253007d9_ex8-1.htm EX-8.1 13830
4 EXHIBIT 8.2 tm253007d9_ex8-2.htm EX-8.2 13539
5 EXHIBIT 10.6 tm253007d9_ex10-6.htm EX-10.6 59641
6 EXHIBIT 23.1 tm253007d9_ex23-1.htm EX-23.1 2048
7 EXHIBIT 23.2 tm253007d9_ex23-2.htm EX-23.2 2450
8 EXHIBIT 23.3 tm253007d9_ex23-3.htm EX-23.3 6750
9 EX-FILING FEES tm253007d9_ex-filingfees.htm EX-FILING FEES 25979
10 GRAPHIC bc_clinical-4clr.jpg GRAPHIC 12265
11 GRAPHIC bc_sibeprenlimab-4clr.jpg GRAPHIC 24782
12 GRAPHIC fc_baff-4clr.jpg GRAPHIC 69902
13 GRAPHIC fc_jademabs-4clr.jpg GRAPHIC 111834
14 GRAPHIC fc_novel-4clr.jpg GRAPHIC 89343
15 GRAPHIC fc_plasma-4clr.jpg GRAPHIC 61470
16 GRAPHIC ft_lucid-bw.jpg GRAPHIC 6470
17 GRAPHIC lc_human-4clr.jpg GRAPHIC 19409
18 GRAPHIC lc_igan-4clr.jpg GRAPHIC 36939
19 GRAPHIC lc_reduction-4clr.jpg GRAPHIC 93220
20 GRAPHIC lc_sibeprenlimab-4clr.jpg GRAPHIC 63472
21 GRAPHIC lc_treatment-4clr.jpg GRAPHIC 63875
22 GRAPHIC lc_upcr-4clr.jpg GRAPHIC 96147
23 GRAPHIC lg_aerovate-4clr.jpg GRAPHIC 14066
24 GRAPHIC lg_jade-4clr.jpg GRAPHIC 13465
25 GRAPHIC lg_lucid-4c.jpg GRAPHIC 9285
26 GRAPHIC px_aerovatecommon25pg01-4c.jpg GRAPHIC 556111
27 GRAPHIC px_aerovatecommon25pg02-4c.jpg GRAPHIC 344833
28 GRAPHIC sg_lucidcapital-bw.jpg GRAPHIC 6325
29 GRAPHIC tb_acei-4clr.jpg GRAPHIC 122389
30 GRAPHIC tb_belimumab-4clr.jpg GRAPHIC 77170
31 GRAPHIC tb_taci-4clr.jpg GRAPHIC 151691
32 GRAPHIC tm253007d9_ex8-1img001.jpg GRAPHIC 3447
33 GRAPHIC tm253007d9_ex8-1img002.jpg GRAPHIC 3447
34 GRAPHIC tm253007d9_ex5-1img001.jpg GRAPHIC 6696
35 GRAPHIC tm253007d9_ex5-1img01.jpg GRAPHIC 2614
  Complete submission text file 0001104659-25-024021.txt   11528322
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4/A | Act: 33 | File No.: 333-283562 | Film No.: 25741296
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)